26.87
Staar Surgical Co (STAA) 最新ニュース
Alcon, STAAR Surgical see US antitrust waiting period expire - MLex
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR - MarketScreener
$1.5B Eye Care Merger Progresses: Alcon's Premium Buyout of STAAR Surgical Clears Key Regulatory Hurdle - Stock Titan
Broadwood files definitive proxy, STAAR reaffirms Alcon merger - Investing.com
Broadwood files definitive proxy, STAAR reaffirms Alcon merger By Investing.com - Investing.com UK
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA and CYBR on Behalf of Shareholders - Benzinga
Alcon: Seeing Is Believing As Buyout Of STAAR Surgical Hangs In Balance (NYSE:ALC) - Seeking Alpha
Yunqi Capital Ltd Increases Stake in Staar Surgical Co - GuruFocus
Key deals this week: STAAR Surgical, Pfizer, DB Insurance, Strive, Rocket Lab and more (PFE:NYSE) - Seeking Alpha
Gwangju Shinsegae Eye Clinic Selected as Best ICL Center for 2 Consecutive Years - 아시아경제
Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors - MSN
STAAR Surgical (STAA) Proposes $28 All-Cash Merger with Alcon - GuruFocus
59% Premium at $28 Per Share: STAAR Surgical Board Champions Alcon Merger as China Sales Decline Continues - Stock Titan
Assenagon Asset Management S.A. Acquires 111,686 Shares of STAAR Surgical Company $STAA - MarketBeat
Alcon’s Deal For STAAR Surgical Faces Pushback From Major Shareholder - Finimize
Intraocular Lens Market Size, Share, Growth, & Demand | Industry Report 2033 - Straits Research
STAAR Surgical (NASDAQ:STAA) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
Alcon AG stock hits 52-week low at $74.83 By Investing.com - Investing.com South Africa
Broadwood opposes Alcon’s acquisition of STAAR Surgical By Investing.com - Investing.com South Africa
STAAR SHAREHOLDER ALERT: Kaskela Law LLC Investigates - GlobeNewswire
Broadwood opposes Alcon’s acquisition of STAAR Surgical - Investing.com
Broadwood Partners (27.5% Owner) Opposes STAAR's $28/Share Alcon Deal | STAA Stock News - Stock Titan
STAAR Surgical’s Shareholder Yunqi Capital Opposes Proposed Merger With Alcon – Here’s Why - Stocktwits
Shareholder Rebellion Intensifies as Staar Surgical Acquisition Reaches Critical Juncture - AD HOC NEWS
STAAR draws no rival bids as Yunqi joins Broadwood against Alcon deal - Investing.com Nigeria
STAAR confirms no competing bids emerged during Alcon merger window By Investing.com - Investing.com Australia
Yunqi Capital opposes STAAR Surgical’s merger with Alcon By Investing.com - Investing.com South Africa
Staar has no competing bids, another shareholder rejects Alcon buy - BioWorld MedTech
STAAR confirms no competing bids emerged during Alcon merger window - Investing.com
Major shareholder Yunqi Capital to vote against Staar Surgical 's proposed sale to Alcon - MSN
Alcon’s Staar Surgical acquisition clears hurdle as ‘window shop’ period closes - MassDevice
51% Premium Deal Stands: STAAR's $28/Share Alcon Merger Remains Unchallenged After 45-Day Shop Period - Stock Titan
Yunqi Capital Opposes Staar Surgical (STAA) Sale to Alcon - GuruFocus
Yunqi Capital opposes STAAR Surgical’s merger with Alcon - Investing.com
Staar Surgical urges shareholders to back Alcon merger as “window shop” period ends (STAA:NASDAQ) - Seeking Alpha
Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon - Bluefield Daily Telegraph
$28 vs Previous $55 Offer: Major STAAR Surgical Investor Yunqi Capital Fights Against 'Undervalued' Alcon Deal - Stock Titan
STAAR SURGICAL CO. STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of STAAR Surgical Company (NASDAQ: STAA) Proposed Stockholder Buyout and Encourages Long-Term Investors to Contact the Firm - ACCESS Newswire
STAAR Surgical Company (NASDAQ:STAA) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Alcon to Buy Staar for $1.5 Billion in Vision Surgery Expansion - MSN
Daily Brief Australia: Alcidion, D3 Energy, Percheron Therapeutics and more - Smartkarma
European Commission grants marketing authorisation to aflibercept biosimilar EYLUXVI (ALT-L9) - Ophthalmology Times Europe
Is STAAR Surgical Poised for a Turnaround After Mixed Earnings in 2025? - Yahoo Finance
Pinnacle Investment Management Ltd Invests $1.16 Million in STAAR Surgical Company $STAA - MarketBeat
Staar Surgical’s board urges stockholders to approve Alcon acquisition in face of scrutiny - MassDevice
51% Premium: Medical Device Leader Alcon to Acquire STAAR Surgical in Premium Cash Deal Worth $28 Per Share - Stock Titan
Cataract Devices Market Estimated at USD 14.68 Billion in 2025 | - openPR.com
Dr. Jason Brinton Selected as Principal Investigator for Landmark FDA Study Demonstrating Superior Safety and Efficacy of EVO ICL Technology - columbiadailyherald.com
Jones Financial Companies Lllp Increases Stock Holdings in STAAR Surgical Company $STAA - MarketBeat
大文字化:
|
ボリューム (24 時間):